Mengchao Wu

5.6k citations
120 papers · 4.5k indexed · h-index 37
Topics
Hepatocellular Carcinoma Treatment and Prognosis (27 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers)Autophagy in Disease and Therapy (12 papers)

In The Last Decade

Mengchao Wu

118 papers receiving 4.4k citations

Peers

Mengchao Wu
Comparison fields: 5 of 116
  • Molecular Biology 1.9k
  • Epidemiology 1.3k
  • Oncology 1.1k
  • Hepatology 1.0k
  • Cancer Research 958
Replace Marco Tripodi with:
Marco Tripodi Italy
Le‐Xing Yu China
Rishu Takimoto Japan
Xingxing He China
George C. Yeoh Australia
Jesper B. Andersen Denmark
Pascal Loyer France
Yuan Yang China
Kinji Asahina Japan
Nathalie Théret France
Mengchao Wu relative to Marco Tripodi Italy Marco Tripodi's profile →
Citations per field
00.5×1.5×
Marco Tripodi · 1×
Citations per year

Countries citing papers authored by Mengchao Wu

Since Specialization
Citations

This map shows the geographic impact of Mengchao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengchao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengchao Wu more than expected).

Fields of papers citing papers by Mengchao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengchao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengchao Wu. The network helps show where Mengchao Wu may publish in the future.

Co-authorship network of co-authors of Mengchao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengchao Wu. A scholar is included among the top collaborators of Mengchao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengchao Wu. Mengchao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 20
3 15
4 33
5 84
6 26
7 1
8 91
9 50
10 47
11 11
12 9
13 10
14 109
15 58
16 159
17 45
18 1
19
THE PREVENTIVE EFFECT OF MATRINE ON RAT HEPATOMA INDUCED BY DIETHYLNITROSAMINE
1
20 3

About Mengchao Wu

Mengchao Wu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 120 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers) and Autophagy in Disease and Therapy (12 papers). The work is most often cited by research in Hepatology (1.0k citations), Cancer Research (958 citations) and Oncology (1.1k citations). Mengchao Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Lixin Wei, Hongyang Wang, Xianling Guo, Jianrui Song, Kai Sun, Qiudong Zhao, Xue Zhao, Shuqun Cheng, Wen‐Ming Cong and Shanshan Zhang. Their work appears in journals such as Science, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026